The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Blood Coagulation: Hemostasis and Thrombin Regulation
Abstract
Perioperative bleeding is a major challenge particularly because of increasing clinical use of potent antithrombotic drugs. Understanding current concepts of coagulation is important in determining the preoperative bleeding risk of patients, and in managing hemostatic therapy perioperatively. The serine protease thrombin plays pivotal roles in the activation of additional serine protease zymogens (inactive enzymatic precursors), cofactors, and cell-surface receptors. Thrombin generation is closely regulated to locally achieve rapid hemostasis after injury without causing uncontrolled systemic thrombosis. During surgery, there are major disturbances in coagulation and inflammatory systems because of hemorrhage/hemodilution, blood transfusion, and surgical stresses. Postoperative bleeding often requires allogeneic blood transfusions, which support thrombin generation and hemostasis. However, procoagulant activity and inflammation are increased postoperatively; thus, antithrombotic therapy may be required to prevent perioperative thrombotic complications. There have been significant advances in the management of perioperative hemostasis and thrombosis because of the introduction of novel hemostatic and antithrombotic drugs. However, a limitation of current treatment is that conventional clotting tests do not reflect the entire physiological processes of coagulation making optimal pharmacologic therapy difficult. Understanding the in vivo regulatory mechanisms and pharmacologic modulation of thrombin generation may help control bleeding without potentially increasing prothrombotic risks. In this review, we focus on the regulatory mechanisms of hemostasis and thrombin generation using multiple, simplified models of coagulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard, G. R., Vincent, J.-L., Laterre, P.-F., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,132
Poort, Sr., Rosendaal, F., Reitsma, P., & Bertina, R. (1996) · Blood · doi:10.1182/blood.v88.10.3698.bloodjournal88103698 · Cited by 3,079
Pharmacology and Management of the Vitamin K Antagonists
Ansell, J., Hirsh, J., Hylek, E., Jacobson, A., Crowther, M., & Palareti, G. (2008) · Chest · doi:10.1378/chest.08-0670 · Cited by 2,118
Antithrombotic Therapy for Venous Thromboembolic Disease
Kearon, C., Kahn, S. R., Agnelli, G., Goldhaber, S., Raskob, G. E., & Comerota, A. J. (2008) · Chest · doi:10.1378/chest.08-0658 · Cited by 1,996
A Cell-based Model of Hemostasis
Monroe, D., & Hoffman, M. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615947 · Cited by 1,542
Weitz, J. I. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709043371007 · Cited by 1,533
The Pharmacology and Management of the Vitamin K Antagonists
Ansell, J., Hirsh, J., Poller, L., Bussey, H., Jacobson, A., & Hylek, E. (2004) · Chest · doi:10.1378/chest.126.3_suppl.204s · Cited by 1,528
Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin.
Hoylaerts, M., Rijken, D. C., Lijnen, H. R., & Collen, D. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)81051-7 · Cited by 1,312
A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke
Mohr, J. P., Thompson, J. L. P., Lazar, R. M., Levin, B., Sacco, R. L., Furie, K. L., Kistler, J. P., Albers, G. W., Pettigrew, L. C., Adams, H. P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011258 · Cited by 1,168
Weitz, J. I., Hudoba, M., Massel, D., Maraganore, J., & Hirsh, J. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114723 · Cited by 1,123
Structure of a serpin–protease complex shows inhibition by deformation
Huntington, J. A., Read, R. J., & Carrell, R. W. (2000) · Nature · doi:10.1038/35038119 · Cited by 1,093
Optimal Oral Anticoagulant Therapy in Patients with Mechanical Heart Valves
Cannegieter, S. C., Rosendaal, F. R., Wintzen, A. R., van der Meer, F. J. M., Vandenbroucke, J. P., & Briet, E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507063330103 · Cited by 908
The origins of age-related proinflammatory state
Ferrucci, L., Corsi, A., Lauretani, F., Bandinelli, S., Bartali, B., Taub, D. D., Guralnik, J. M., & Longo, D. L. (2005) · Blood · doi:10.1182/blood-2004-07-2599 · Cited by 908
The Perioperative Management of Antithrombotic Therapy
Douketis, J. D., Berger, P. B., Dunn, A. S., Jaffer, A. K., Spyropoulos, A. C., Becker, R. C., & Ansell, J. (2008) · Chest · doi:10.1378/chest.08-0675 · Cited by 830
Factor XI Activation in a Revised Model of Blood Coagulation
Gailani, D., & Broze, G. J. (1991) · Science · doi:10.1126/science.1652157 · Cited by 775
The cytoprotective protein C pathway
Mosnier, L. O., Zlokovic, B. V., & Griffin, J. H. (2007) · Blood · doi:10.1182/blood-2006-09-003004 · Cited by 754
Acute Traumatic Coagulopathy: Initiated by Hypoperfusion: Modulated Through the Protein C Pathway?
Brohi, K., Cohen, M. J., Ganter, M. T., Matthay, M. A., Mackersie, R. C., & Pittet, J.-F. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000256862.79374.31 · Cited by 736
Esmon, C. T. (2003) · Chest · doi:10.1378/chest.124.3_suppl.26s · Cited by 719
Hemostatic Factors and Replacement of Major Blood Loss with Plasma-Poor Red Cell Concentrates
Hiippala, S. T., Myllyla, G. J., & Vahtera, E. M. (1995) · Anesthesia & Analgesia · doi:10.1097/00000539-199508000-00026 · Cited by 703
Ganter, M. T., & Hofer, C. K. (2008) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e318168b367 · Cited by 677
Thromboembolic Adverse Events After Use of Recombinant Human Coagulation Factor VIIa
O’Connell, K. A. (2006) · JAMA · doi:10.1001/jama.295.3.293 · Cited by 671
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
Albers, G. W., Easton, J. D., Sacco, R. L., & Teal, P. (1998) · Chest · doi:10.1378/chest.114.5_supplement.683s · Cited by 617
Antithrombotic Therapy in Atrial Fibrillation
Singer, D. E., Albers, G. W., Dalen, J. E., Go, A. S., Halperin, J. L., & Manning, W. J. (2004) · Chest · doi:10.1378/chest.126.3_suppl.429s · Cited by 547
Prevention and Treatment of Major Blood Loss
Mannucci, P. M., & Levi, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmra067742 · Cited by 494
Ni, H., Denis, C. V., Subbarao, S., Degen, J. L., Sato, T. N., Hynes, R. O., & Wagner, D. D. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9896 · Cited by 492
Evolution of the proteases of blood coagulation and fibrinolysis by assembly from modules
Patthy, L. (1985) · Cell · doi:10.1016/s0092-8674(85)80046-5 · Cited by 491
Warkentin, T., Hayward, C., Boshkov, L., Santos, A., Sheppard, J., Bode, A., & Kelton, J. (1994) · Blood · doi:10.1182/blood.v84.11.3691.bloodjournal84113691 · Cited by 478
Platelet Function Monitoring in Patients With Coronary Artery Disease
Gurbel, P. A., Becker, R. C., Mann, K. G., Steinhubl, S. R., & Michelson, A. D. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.07.051 · Cited by 478
Astermark, J., Donfield, S. M., DiMichele, D. M., Gringeri, A., Gilbert, S. A., Waters, J., Berntorp, E., & for the FENOC Study Group (2007) · Blood · doi:10.1182/blood-2006-04-017988 · Cited by 473
Thrombin generation, a function test of the haemostaticthrombotic system
Al Dieri, R., De Smedt, E., Béguin, S., & Hemker, H. (2006) · Thrombosis and Haemostasis · doi:10.1160/th06-07-0408 · Cited by 467
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
Albers, G. W., Amarenco, P., Easton, J. D., Sacco, R. L., & Teal, P. (2004) · Chest · doi:10.1378/chest.126.3_suppl.483s · Cited by 466
Esmon, C. T. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00261.x · Cited by 442
Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor.
Sakata, Y., & Aoki, N. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109671 · Cited by 396
Heparin induces release of extrinsic: Coagulation pathway inhibitor (EPI)
Sandset, P. M., Abildgaard, U., & Larsen, M. L. (1988) · Thrombosis Research · doi:10.1016/0049-3848(88)90340-4 · Cited by 386
Chowdhury, P., Saayman, A. G., Paulus, U., Findlay, G. P., & Collins, P. W. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04868.x · Cited by 381
Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk
Juhan-Vague, I., Alessi, M.-C., Mavri, A., & Morange, P. E. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00279.x · Cited by 371 · cited 1×
“PAI-1 is a serine protease inhibitor synthesized in the liver and endothelium, and its expression is increased in inflammatory states.(139)”
BackgroundCoagulation in arthropods: defence, wound closure and healing
Theopold, U., Schmidt, O., Söderhäll, K., & Dushay, M. S. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.03.004 · Cited by 370
Swan, S. K., & Hursting, M. J. (2000) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.4.318.34881 · Cited by 368
Correlation between fibrinogen binding to human platelets and platelet aggregability
Peerschke, E., Zucker, M., Grant, R., Egan, J., & Johnson, M. (1980) · Blood · doi:10.1182/blood.v55.5.841.841 · Cited by 358
Leissinger, C. A., Blatt, P. M., Hoots, W. K., & Ewenstein, B. (2008) · American Journal of Hematology · doi:10.1002/ajh.21046 · Cited by 353
Branson, H., Marble, R., Katz, J., & Griffin, J. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91216-3 · Cited by 342
Spatial and temporal dynamics of the endothelium
AIRD, W. C. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01328.x · Cited by 341
(2019) · Springer eBooks · doi:10.1007/978-3-030-19330-0 · Cited by 308
Lane, D. A., Philippou, H., & Huntington, J. A. (2005) · Blood · doi:10.1182/blood-2005-04-1710 · Cited by 307
Relationship between platelet count and bleeding risk in thrombocytopenic patients
SLICHTER, S. (2004) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2004.03.003 · Cited by 305
Molecular basis of vitamin K-dependent gamma-carboxylation
Furie, B., & Furie, B. (1990) · Blood · doi:10.1182/blood.v75.9.1753.1753 · Cited by 285
Iwanaga, S., Kawabata, S.-I., & Muta, T. (1998) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021894 · Cited by 284
Ely, E. W., Laterre, P.-F., Angus, D. C., Helterbrand, J. D., Levy, H., Dhainaut, J.-F., Vincent, J.-L., Macias, W. L., & Bernard, G. R. (2003) · Critical Care Medicine · doi:10.1097/00003246-200301000-00002 · Cited by 283
Thrombin, Thrombomodulin and TAFI in the Molecular Link Between Coagulation and Fibrinolysis
Nesheim, M., Wang, W., Boffa, M., Nagashima, M., Morser, J., & Bajzar, L. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657557 · Cited by 258
Hypercoagulability in centenarians: the paradox of successful aging
Mari, D., Mannucci, P., Coppola, R., Bottasso, B., Bauer, K., & Rosenberg, R. (1995) · Blood · doi:10.1182/blood.v85.11.3144.bloodjournal85113144 · Cited by 257
Despotis, G. J., Filos, K. S., Zoys, T. N., Hogue, C. W., Spitznagel, E., & Lappas, D. G. (1996) · Anesthesia & Analgesia · doi:10.1097/00000539-199601000-00004 · Cited by 254
The Primary and Secondary Prevention of Coronary Artery Disease
Becker, R. C., Meade, T. W., Berger, P. B., Ezekowitz, M., O'Connor, C. M., Vorchheimer, D. A., Guyatt, G. H., Mark, D. B., & Harrington, R. A. (2008) · Chest · doi:10.1378/chest.08-0685 · Cited by 249
de Agostini, A. I., Watkins, S. C., Slayter, H. S., Youssoufian, H., & Rosenberg, R. D. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.3.1293 · Cited by 239
Human Pulmonary Endothelial Cells in Culture
Johnson, A. R. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109736 · Cited by 229
Regulation of Extrinsic Pathway Factor Xa Formation by Tissue Factor Pathway Inhibitor
Baugh, R. J., Broze, G. J., & Krishnaswamy, S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.8.4378 · Cited by 226
Inactivation of C3a and C5a Octapeptides by Carboxypeptidase R and Carboxypeptidase N
Campbell, W. D., Lazoura, E., Okada, N., & Okada, H. (2002) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2002.tb02669.x · Cited by 224
Tissue Distribution and Regulation of Murine von Willebrand Factor Gene Expression In Vivo
Yamamoto, K., de Waard, V., Fearns, C., & Loskutoff, D. J. (1998) · Blood · doi:10.1182/blood.v92.8.2791 · Cited by 222
Management of massive blood loss: a template guideline
Stainsby, D., MacLennan, S., & Hamilton, P. J. (2000) · British Journal of Anaesthesia · doi:10.1093/bja/85.3.487 · Cited by 213
Beyond Unfractionated Heparin and Warfarin: Current and Future Advances
Hirsh, J., O’Donnell, M., & Eikelboom, J. W. (2007) · Circulation · doi:10.1161/circulationaha.106.685974 · Cited by 211
Greiner, A., & Nicolson, G. (1965) · The Lancet · doi:10.1016/s0140-6736(65)92564-x · Cited by 201
Vascular bed-specific hemostasis: Role of endothelium in sepsis pathogenesis
Aird, W. C. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107001-00013 · Cited by 200
Heparin-Induced Thrombocytopenia: Diagnosis and Management
Warkentin, T. E. (2004) · Circulation · doi:10.1161/01.cir.0000147537.72829.1b · Cited by 199
Congenital Deficiency of α2-Plasmin Inhibitor Associated with Severe Hemorrhagic Tendency *
Aoki, N., Saito, H., Kamiya, T., Koie, K., Sakata, Y., & Kobakura, M. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109387 · Cited by 197
Molecular markers of serine protease evolution
Krem, M. M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.12.3036 · Cited by 196
Tripodi, A., Chantarangkul, V., Primignani, M., Fabris, F., Dell'Era, A., Sei, C., & Mannuccio Mannucci, P. (2007) · Hepatology · doi:10.1002/hep.21732 · Cited by 196
Preston, F. E., Laidlaw, S. T., Sampson, B., & Kitchen, S. (2002) · British Journal of Haematology · doi:10.1046/j.0007-1048.2001.03295.x · Cited by 188
Estrogens, progestogens and thrombosis
Rosendaal, F. R., Van Hylckama Vlieg, A., Tanis, B. C., & Helmerhorst, F. M. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00264.x · Cited by 188
Ringrose, A., Zhou, Y., Pang, E., Lin, A. E.-J., Li, X.-J., Li, I., Weng, A., & Jiang, X. (2005) · Blood · doi:10.1182/blood.v106.11.2605.2605 · Cited by 188
Addiction and Substance Abuse in Anesthesiology
Bryson, E. O., Silverstein, J. H., Warner, D. S., & Warner, M. A. (2008) · Anesthesiology · doi:10.1097/aln.0b013e3181895bc1 · Cited by 186
Thrombomodulin, an endothelial anticoagulant protein, is absent from the human brain
Ishii, H., Salem, H., Bell, C., Laposata, E., & Majerus, P. (1986) · Blood · doi:10.1182/blood.v67.2.362.362 · Cited by 183
Genetic Determinants of Arterial Thrombosis
Voetsch, B., & Loscalzo, J. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000107402.79771.fc · Cited by 181
PAR1 Cleavage and Signaling in Response to Activated Protein C and Thrombin
Ludeman, M. J., Kataoka, H., Srinivasan, Y., Esmon, N. L., Esmon, C. T., & Coughlin, S. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410381200 · Cited by 180
Douketis, J. D. (2002) · Thrombosis Research · doi:10.1016/s0049-3848(02)00387-0 · Cited by 178
Mosnier, L. O., & Bouma, B. N. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000244680.14653.9a · Cited by 173
Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates.
Hanson, S. R., Griffin, J. H., Harker, L. A., Kelly, A. B., Esmon, C. T., & Gruber, A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116795 · Cited by 171
450 million years of hemostasis
Davidson, C. J., Tuddenham, E. G., & McVey, J. H. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00334.x · Cited by 169
Monković, D. D., & Tracy, P. B. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44879-4 · Cited by 164
van Aart, L., Eijkhout, H. W., Kamphuis, J. S., Dam, M., Schattenkerk, M. E., Schouten, T. J., Ploeger, B., & Strengers, P. F. W. (2006) · Thrombosis Research · doi:10.1016/j.thromres.2005.08.005 · Cited by 161
Perioperative Hemostatic Management of Patients Treated with Vitamin K Antagonists
Levy, J. H., Tanaka, K. A., & Dietrich, W. (2008) · Anesthesiology · doi:10.1097/aln.0b013e3181895bd8 · Cited by 158
Self-citationSvensson, P., Dahlbäck, B., Maršál, K., & Lindqvist, P. G. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614222 · Cited by 143
Von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura
Moake, J. L. (2004) · Seminars in Hematology · doi:10.1053/j.seminhematol.2003.10.003 · Cited by 131
EMEIS, J. J. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb51622.x · Cited by 131
Thrombophilia: Common Questions on Laboratory Assessment and Management
Heit, J. A. (2007) · Hematology · doi:10.1182/asheducation-2007.1.127 · Cited by 131
Wettstein, P., Haeberli, A., Stutz, M., Rohner, M., Corbetta, C., Gabi, K., Schnider, T. W., & Korte, W. C. (2004) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000134800.46276.21 · Cited by 125
Lambert, M. P., Rauova, L., Bailey, M. H., et al. (2007) · Blood · doi:10.1182/blood-2007-01-067116 · Cited by 125
Ofosu, F. A., Siè, P., Modi, G. J., Fernandez, F., Buchanan, M. R., Blajchman, M. A., Boneu, B., & Hirsh, J. (1987) · Biochemical Journal · doi:10.1042/bj2430579 · Cited by 123
Inflammation and Atherothrombosis
ROBBIE, L. A., & Libby, P. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03939.x · Cited by 115
Pharmacology of emerging novel platelet inhibitors
Angiolillo, D. J., & Capranzano, P. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.06.004 · Cited by 114
Anticoagulation in Hospitalized Patients With Renal Insufficiency
Thorevska, N. Y., Amoateng‐Adjepong, Y., Sabahi, R., Schiopescu, I., Salloum, A., Muralidharan, V., & Manthous, C. A. (2004) · CHEST Journal · doi:10.1378/chest.125.3.856 · Cited by 109
Platelet deposition inhibits tissue factor activity: in vitro clots are impermeable to factor Xa
Hathcock, J. J., & Nemerson, Y. (2004) · Blood · doi:10.1182/blood-2003-12-4352 · Cited by 102
Formation of Factors IXa and Xa by the Extrinsic Pathway
Lu, G., Broze, G., & Krishnaswamy, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312827200 · Cited by 86
Protease-Activated Receptors and Platelet Function
Coughlin, S. R. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615853 · Cited by 85
Shworak, N. W., HajMohammadi, S., de Agostini, A. I., & Rosenberg, R. D. (2002) · Glycoconjugate Journal · doi:10.1023/a:1025377206600 · Cited by 77
Alesh, I., Kayali, F., & Stein, P. D. (2007) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.21079 · Cited by 76
Inherited Risk Factors for Venous Thrombosis
Cushman, M. (2005) · Hematology · doi:10.1182/asheducation-2005.1.452 · Cited by 76
Lo, B., Fijnheer, R., Castigliego, D., Borst, C., Kalkman, C. J., & Nierich, A. P. (2004) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000130257.64006.5c · Cited by 72
The partial thromboplastin time: defining an era in coagulation
White, G. C. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00459.x · Cited by 72
Epidemiology and pathogenesis of venous thrombosis
Hirsh, J., Hull, R. D., & Raskob, G. E. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80012-2 · Cited by 72
Competition between plasminogen and tissue plasminogen activator for cellular binding sites
Félez, J., Chanquia, C., Fabregas, P., Plow, E., & Miles, L. A. (1993) · Blood · doi:10.1182/blood.v82.8.2433.2433 · Cited by 65
Recombinant Human Transgenic Antithrombin in Cardiac Surgery
Levy, J. H., Despotis, G. J., Szlam, F., Olson, P. J., Meeker, D. P., & Weisinger, A. S. (2002) · Anesthesiology · doi:10.1097/00000542-200205000-00011 · Cited by 61
Self-citationThe Effect of Factor XIII on Bleeding in Coronary Surgery
Gödje, O. L., Haushofer, M., Lamm, P., & Reichart, B. (1998) · The Thoracic and Cardiovascular Surgeon · doi:10.1055/s-2007-1010236 · Cited by 59
Antithrombin Deficiency Increases Thrombin Activity After Prolonged Cardiopulmonary Bypass
Sniecinski, R. M., Szlam, F., Chen, E. P., Bader, S. O., Levy, J. H., & Tanaka, K. A. (2008) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181608f7c · Cited by 57
Self-citationNew anticoagulants: beyond heparin, low‐molecular‐weight heparin and warfarin
Bates, S. M., & Weitz, J. I. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706153 · Cited by 56
Time trends in warfarin-associated hemorrhage
Kucher, N., Castellanos, L. R., Quiroz, R., et al. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.04.050 · Cited by 52
Liestøl, S., Sandset, P. M., Jacobsen, E. M., Mowinckel, M., & Wislöff, F. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06385.x · Cited by 51
Heindl, B., DeLorenzo, C., & Spannagl, M. (2005) · Der Anaesthesist · doi:10.1007/s00101-005-0865-7 · Cited by 51
Wielders, S. J. H., Beguı́n, S., Hemker, H. C., et al. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000128125.80559.9c · Cited by 49
Lee, A. Y. Y. (2006) · Hematology · doi:10.1182/asheducation-2006.1.438 · Cited by 47
Temporal trends in the prescription of vitamin K antagonists in patients with atrial fibrillation
Friberg, J., Gislason, G., Gadsbøll, N., Rasmussen, J. N., RASMUSSEN, S., Abildstrom, S. Z., Køber, L., Madsen, M., & Torp-Pedersen, C. T. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01595.x · Cited by 36
Parolari, A., Mussoni, L., Frigerio, M., Naliato, M., Alamanni, F., Polvani, G., Agrifoglio, M., Veglia, F., Tremoli, E., Biglioli, P., et al. (2005) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2005.07.049 · Cited by 28
Sniecinski, R. M., Chen, E. P., & Tanaka, K. A. (2008) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e3282f40d4a · Cited by 27
Self-citationSzlam, F., Taketomi, T., Sheppard, C., Kempton, C. L., Levy, J. H., & Tanaka, K. A. (2008) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181618702 · Cited by 18
Self-citation
Cited by
Ramírez, D., & Caballero, J. (2018) · Molecules · doi:10.3390/molecules23051038 · Cited by 624
Vascular endothelium – Gatekeeper of vessel health
Cahill, P. A., & Redmond, E. M. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.03.007 · Cited by 518
Boron Containing Compounds as Protease Inhibitors
Smoum, R., Rubinstein, A., Dembitsky, V. M., & Srebnik, M. (2012) · Chemical Reviews · doi:10.1021/cr608202m · Cited by 450
Pathophysiology and Treatment of Coagulopathy in Massive Hemorrhage and Hemodilution
Bolliger, D., Görlinger, K., Tanaka, K. A., & Warner, D. S. (2010) · Anesthesiology · doi:10.1097/aln.0b013e3181f22b5a · Cited by 325
Self-citationKarkouti, K., Callum, J., Wijeysundera, D. N., Rao, V., Crowther, M., Grocott, H. P., Pinto, R., Scales, D. C., Achen, B., Brar, S., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.023956 · Cited by 318
Metadata
- Authors
- Tanaka, K. A., Key, N. S., & Levy, J. H.
- Venue
- Anesthesia & Analgesia
- Published
- 2009-05
- Volume
- 108
- Issue
- 5
- Pages
- 1433-1446
- ISSN
- 0003-2999 (ISSN-L)
- OpenAlex
- W2060972622
- Cited by
- 342
- References
- 113
- FWCI
- 17.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.